Proprietary AI analyst is now available

Medplus Health Services Valuation Multiples

Discover revenue and EBITDA valuation multiples for Medplus Health Services and similar public comparables like Aldawaa Medical Services, Pets at Home, Foschini Group, Sally Beauty Holdings and more.

Medplus Health Services Overview

About Medplus Health Services

Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.


Founded

2006

HQ

India

Employees

1.3K

Financials (LTM)

Revenue: $735M
EBITDA: $66M

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Medplus Health Services Financials

Medplus Health Services reported last 12-month revenue of $735M and EBITDA of $66M.

In the same LTM period, Medplus Health Services generated $194M in gross profit, $66M in EBITDA, and $24M in net income.

Revenue (LTM)


Medplus Health Services P&L

In the most recent fiscal year, Medplus Health Services reported revenue of $717M and EBITDA of $71M.

Medplus Health Services is profitable as of last fiscal year, with gross margin of 26%, EBITDA margin of 10%, and net margin of 3%.

See analyst estimates for Medplus Health Services
LTMLast FY202320242025202620272028
Revenue$735M$717M$552M$620M$696M
Gross Profit$194M$188M$117M$144M$179M
Gross Margin26%26%21%23%26%
EBITDA$66M$71M$39M$52M$67M
EBITDA Margin9%10%7%8%10%
EBIT Margin5%5%2%4%5%
Net Profit$24M$23M$6M$13M$21M
Net Margin3%3%1%2%3%

Financial data powered by Morningstar, Inc.

Medplus Health Services Stock Performance

Medplus Health Services has current market cap of $1B, and enterprise value of $1B.

Market Cap Evolution


Medplus Health Services' stock price is $8.95.

Medplus Health Services share price decreased by 5.3% in the last 30 days, and by 8.1% in the last year.

Medplus Health Services has an EPS (earnings per share) of $0.19.

See more trading valuation data for Medplus Health Services
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$1B-5.0%-5.3%-0.3%-8.1%$0.19

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Medplus Health Services Valuation Multiples

Medplus Health Services trades at 1.6x EV/Revenue multiple, and 17.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Medplus Health Services

EV / Revenue (LTM)


Medplus Health Services Financial Valuation Multiples

As of June 5, 2026, Medplus Health Services has market cap of $1B and EV of $1B.

Medplus Health Services has a P/E ratio of 45.0x.

LTMLast FY202320242025202620272028
EV/Revenue1.6x1.6x2.1x1.9x1.7x
EV/EBITDA17.7x16.4x29.8x22.3x17.3x
EV/EBIT31.4x32.4x92.5x52.6x36.8x
EV/Gross Profit6.0x6.2x9.9x8.1x6.5x
P/E45.0x46.4x167.9x80.0x51.1x
EV/FCF35.8x29.9xn/m29.7x27.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Medplus Health Services Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Medplus Health Services Margins & Growth Rates

Medplus Health Services grew revenue by 14% and EBITDA by 6% in the last fiscal year.

In the most recent fiscal year, Medplus Health Services reported gross margin of 26%, EBITDA margin of 10%, and net margin of 3%.

See estimated margins and future growth rates for Medplus Health Services

Medplus Health Services Margins

Last FY202420252026202720282029
Gross Margin26%23%26%27%
EBITDA Margin10%8%10%9%
EBIT Margin5%4%5%5%
Net Margin3%2%3%3%
FCF Margin5%6%6%4%

Medplus Health Services Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth14%12%12%14%
Gross Profit Growth17%22%24%18%
EBITDA Growth6%34%29%10%
EBIT Growth18%76%43%27%
Net Profit Growth18%110%57%25%
FCF Growth(17%)1411%6%(18%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Medplus Health Services Operational KPIs

Medplus Health Services' revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.1M for the same period.

Medplus Health Services' Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Medplus Health Services' Rule of X is 44% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Medplus Health Services
LTMLast FY202320242025202620272028
Rule of 4023%23%---
Bessemer Rule of X45%44%---
Revenue per Employee-$0.6M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue--2%2%2%
G&A Expenses to Revenue--0%0%0%
Opex to Revenue-22%19%20%21%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Medplus Health Services Competitors

Medplus Health Services competitors include Aldawaa Medical Services, Pets at Home, Foschini Group, Sally Beauty Holdings, Douglas, Carasso Motors, JINS Holdings, Siam Global House, Anhui Huaren Health and Yixintang Pharmaceutical.

Most Medplus Health Services public comparables operate across Pharmacies and Specialty Stores.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Aldawaa Medical Services0.9x0.9x6.8x7.2x
Pets at Home0.8x0.8x4.9x5.5x
Foschini Group0.7x0.7x3.4x3.5x
Sally Beauty Holdings0.7x0.7x5.7x5.8x
Douglas0.6x0.6x3.8x3.9x
Carasso Motors1.4x-7.8x-
JINS Holdings1.8x1.7x11.6x10.6x
Siam Global House1.4x1.4x11.6x11.3x

This data is available for Pro users. Sign up to see all Medplus Health Services competitors and their valuation data.

Start Free Trial

Medplus Health Services VC Funding History

Before going public, Medplus Health Services raised $204M in total equity funding, across 4 rounds.

Last private valuation of Medplus Health Services was $412M, after raising $14M in February 2021 from Premji Invest and Warburg Pincus.


Medplus Health Services Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Aug-24Secondary - publicGovernment of Singapore; ICICI Prudential Asset Management$100M-MedPlus Health Services is one of India's leading pharmacy chains, operating 4,712 stores across 13 states and 1 union territory in over 700 cities as of March 31, 2025. It provides pharmaceutical products, online pharmacy, path labs, and optical services, with a focus on cluster-based expansion and technology-driven supply chain. The company launched MedPlus-branded products reaching GMV of Rs 14,025.52 million in FY2024. On August 26, 2024, the Government of Singapore and ICICI Prudential Mutual Fund acquired a 5.2% stake (62.45 lakh shares) in MedPlus Health Services at Rs 616-616.20 per share, valuing the transaction at Rs 384.72 crore. This followed Warburg Pincus exiting its entire 11.35% stake (1.35 crore shares) at Rs 616.48 per share for Rs 836.16 crore via open market transactions on NSE. Shares settled at Rs 638.50 that day. MedPlus reported revenue from operations of Rs 4,558 crore for FY2024 (ended March 2024), up 20.59% from Rs 3,779 crore in FY2023, and Rs 6,136.05 crore for FY2025. Profit after tax was Rs 150.23 crore in FY2025, up from Rs 656 million in FY24. For Q1 FY2025 (ended June 30, 2024), revenue was Rs 14,975.37 million.
Feb-21Undisclosed stagePremji Invest; Warburg Pincus$14M$412MMedplus Health Services operates one of India's largest pharmacy retail chains, with over 4,000 stores across 581 cities as of recent reports. The company offers prescription and over-the-counter medications, wellness products, healthcare essentials, and FMCG items like toiletries and baby care through physical stores and an online platform. It launched its first pharmacy in Hyderabad in February 2006 and serves more than 350,000 customers daily. In February 2021, Warburg Pincus invested Rs 77.78 crore through Lavender Rose Investment and Premji Invest committed Rs 22.21 crore through PI Opportunities Fund-I, totaling around $13.68 million ahead of the company's IPO preparations. Warburg Pincus later reduced its stake by selling 6.2% for Rs 550 crore at Rs 796 per share before the December 2021 IPO and fully exited its 11.35% holding for Rs 836 crore at Rs 616.48 per share in a later open market transaction. For FY2021, Medplus reported revenue from operations of INR 1,489 crore and Operating EBITDA of INR 175.06 crore, reflecting a 63.21% CAGR in EBITDA from FY2019. Average revenue per store was approximately Rs 1.59 crore, with mature stores showing 11% Store Level Operating EBITDA margin and compounded same store sales growth of 8.30% on MRP from FY2019 to FY2021.
Dec-17Series C-$1M--
Nov-14Series CMount Kellett Capital Management$90M-MedPlus Health Services is a Hyderabad-based retail pharmacy chain founded in 2006, operating over 1,240 pharmacies across India by 2015, competing with Apollo Pharmacy and Guardian Lifecare in the organized pharma retail sector. The company offers pharmacy services, diagnostic labs, clinics, and launched an e-commerce initiative 'Click, Pick & Save' for online medicine ordering and comparison. In March 2011, Mount Kellett Capital Management, TVS Capital, and Ajay Piramal's healthcare fund acquired around 34-35% stake from Arcapita Bank for Rs 410 crore ($90 million), valuing the company at over Rs 1,200 crore ($260 million) at that time, with Mount Kellett leading the investment of approximately Rs 300 crore. No specific VC equity funding round by Mount Kellett in October 2014 was identified; references point to the 2011 investment. By FY 2014-15, MedPlus reported turnover of Rs 1,430 crore, up 33% from Rs 1,080 crore in the prior year, reflecting strong growth amid rising healthcare needs and competition from unorganized mom-and-pop stores holding 90% market share. The company planned expansion to 10,000 stores over four years, requiring Rs 2,000 crore, while ruling out inorganic growth or IPO. Later developments included plans in 2015 to raise Rs 75 million with existing backers TVS Capital and Mount Kellett, who together with others held significant stakes (Mount Kellett at 49%, TVS at 10.59% in some reports, totaling around 69%). By mid-2015, the company was put up for sale with Credit Suisse seeking buyers for 51-74% stake at a targeted Rs 2,700 crore valuation (about 2x sales on Rs 1,200-1,300 crore revenues), though analysts suggested 1-1.5x sales as more realistic; investors sought over 3x returns on their 2011 investment.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Medplus Health Services

When was Medplus Health Services founded?Medplus Health Services was founded in 2006.
Where is Medplus Health Services headquartered?Medplus Health Services is headquartered in India.
How many employees does Medplus Health Services have?As of today, Medplus Health Services has over 1K employees.
Who is the CEO of Medplus Health Services?Medplus Health Services' CEO is Gangadi Madhukar Reddy.
Is Medplus Health Services publicly listed?Yes, Medplus Health Services is a public company listed on National Stock Exchange of India.
What is the stock symbol of Medplus Health Services?Medplus Health Services trades under MEDPLUS ticker.
When did Medplus Health Services go public?Medplus Health Services went public in 2021.
Who are competitors of Medplus Health Services?Medplus Health Services main competitors include Aldawaa Medical Services, Pets at Home, Foschini Group, Sally Beauty Holdings, Douglas, Carasso Motors, JINS Holdings, Siam Global House, Anhui Huaren Health, Yixintang Pharmaceutical.
What is the current market cap of Medplus Health Services?Medplus Health Services' current market cap is $1B.
What is the current revenue of Medplus Health Services?Medplus Health Services' last 12 months revenue is $735M.
What is the current revenue growth of Medplus Health Services?Medplus Health Services revenue growth (NTM/LTM) is 14%.
What is the current EV/Revenue multiple of Medplus Health Services?Current revenue multiple of Medplus Health Services is 1.6x.
What is the current EBITDA of Medplus Health Services?Medplus Health Services' last 12 months EBITDA is $66M.
What is Medplus Health Services' EBITDA margin?Medplus Health Services' last 12 months EBITDA margin is 9%.
What is the current EV/EBITDA multiple of Medplus Health Services?Current EBITDA multiple of Medplus Health Services is 17.7x.
What is the current FCF of Medplus Health Services?Medplus Health Services' last 12 months FCF is $32M.
What is Medplus Health Services' FCF margin?Medplus Health Services' last 12 months FCF margin is 4%.
What is the current EV/FCF multiple of Medplus Health Services?Current FCF multiple of Medplus Health Services is 35.8x.
How many companies Medplus Health Services has acquired to date?Medplus Health Services hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Medplus Health Services has invested to date?Medplus Health Services hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Medplus Health Services

Lists including Medplus Health Services

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial